Health3 months ago
Fortress Biotech Surges Following FDA Approval of Zycubo Therapy
Fortress Biotech experienced a surge of approximately 10% in premarket trading on October 10, 2023, following the approval of its copper replacement therapy, Zycubo (CUTX-101), by...
